Skip to content
  • Home
  • About us
    • History
    • Management and board
    • Our team
    • Quality Assurance
    • R&D
      • R&D
      • Co-development & licensing
    • Partners
    • Testimonials
    • Privacy statement
    • Company video
  • Services
    • Cancer models
      • In vitro assays
      • Immuno-Oncology
      • Humanized mouse models
      • Breast cancer
      • Prostate cancer
      • Multiple myeloma
      • Pancreatic cancer
    • Skeletal disease models
      • In vitro assays, osteoclasts
      • In vitro assays, osteoblasts
      • Postmenopausal osteoporosis
      • Male osteoporosis
      • Glucocorticoid-induced osteoporosis
      • Osteoarthritis
      • Osteogenesis imperfecta
    • Models of hormonal action
      • In vitro assay, androgenic activity
      • In vitro assay, estrogenic activity
      • Hershberger bioassay
      • Uterotrophic bioassay
    • Bone safety
    • Bone analysis services
    • Clinical biomarker services
    • Radiopharmaceuticals testing expertise
    • Pain assessment
    • Statistics
    • Why choose Pharmatest?
  • Facilities & equipment
  • Downloads
    • Fact sheets
    • White papers
    • Scientific presentations
      • Cancer
      • Skeletal
    • Scientific publications
  • News
  • Contact us
Menu
  • Home
  • About us
    • History
    • Management and board
    • Our team
    • Quality Assurance
    • R&D
      • R&D
      • Co-development & licensing
    • Partners
    • Testimonials
    • Privacy statement
    • Company video
  • Services
    • Cancer models
      • In vitro assays
      • Immuno-Oncology
      • Humanized mouse models
      • Breast cancer
      • Prostate cancer
      • Multiple myeloma
      • Pancreatic cancer
    • Skeletal disease models
      • In vitro assays, osteoclasts
      • In vitro assays, osteoblasts
      • Postmenopausal osteoporosis
      • Male osteoporosis
      • Glucocorticoid-induced osteoporosis
      • Osteoarthritis
      • Osteogenesis imperfecta
    • Models of hormonal action
      • In vitro assay, androgenic activity
      • In vitro assay, estrogenic activity
      • Hershberger bioassay
      • Uterotrophic bioassay
    • Bone safety
    • Bone analysis services
    • Clinical biomarker services
    • Radiopharmaceuticals testing expertise
    • Pain assessment
    • Statistics
    • Why choose Pharmatest?
  • Facilities & equipment
  • Downloads
    • Fact sheets
    • White papers
    • Scientific presentations
      • Cancer
      • Skeletal
    • Scientific publications
  • News
  • Contact us
  • Request a Quote
Menu
  • Request a Quote

Company video

About our
Company

  • History
  • Management and board
  • Our team
  • Quality Assurance
  • R&D
    • R&D
    • Co-development & licensing
  • Partners
  • Testimonials
  • Privacy statement
  • Company video
Menu
  • History
  • Management and board
  • Our team
  • Quality Assurance
  • R&D
    • R&D
    • Co-development & licensing
  • Partners
  • Testimonials
  • Privacy statement
  • Company video
p_letter_mediumblue

Headquarters, Research laboratories

Pharmatest Services
Itäinen Pitkäkatu 4 A, 5th floor
20520 Turku
FINLAND

+358 2 278 4700

Pharmatest USA

25B Stow Road
Boxborough, MA 01719
USA

+1 978.340.1028

China Agency Office

Guangzhou Gucon Biotech Co., Ltd
Rm.302-304, D#, Chuangxin Base
No.80, Lanyue Rd., Guangzhou Science City
Luogang, Guangzhou, Guangdong
China

sales.china@pharmatest.com

Linkedin

© 2021 Pharmatest Services

Privacy Policy

Website: Sivustamo Oy
  • Home
  • About us
    • History
    • Management and board
    • Our team
    • Quality Assurance
    • R&D
      • R&D
      • Co-development & licensing
    • Partners
    • Testimonials
    • Privacy statement
    • Company video
  • Services
    • Cancer models
      • In vitro assays
      • Immuno-Oncology
      • Humanized mouse models
      • Breast cancer
      • Prostate cancer
      • Multiple myeloma
      • Pancreatic cancer
    • Skeletal disease models
      • In vitro assays, osteoclasts
      • In vitro assays, osteoblasts
      • Postmenopausal osteoporosis
      • Male osteoporosis
      • Glucocorticoid-induced osteoporosis
      • Osteoarthritis
      • Osteogenesis imperfecta
    • Models of hormonal action
      • In vitro assay, androgenic activity
      • In vitro assay, estrogenic activity
      • Hershberger bioassay
      • Uterotrophic bioassay
    • Bone safety
    • Bone analysis services
    • Clinical biomarker services
    • Radiopharmaceuticals testing expertise
    • Pain assessment
    • Statistics
    • Why choose Pharmatest?
  • Facilities & equipment
  • Downloads
    • Fact sheets
    • White papers
    • Scientific presentations
      • Cancer
      • Skeletal
    • Scientific publications
  • News
  • Contact us
Menu
  • Home
  • About us
    • History
    • Management and board
    • Our team
    • Quality Assurance
    • R&D
      • R&D
      • Co-development & licensing
    • Partners
    • Testimonials
    • Privacy statement
    • Company video
  • Services
    • Cancer models
      • In vitro assays
      • Immuno-Oncology
      • Humanized mouse models
      • Breast cancer
      • Prostate cancer
      • Multiple myeloma
      • Pancreatic cancer
    • Skeletal disease models
      • In vitro assays, osteoclasts
      • In vitro assays, osteoblasts
      • Postmenopausal osteoporosis
      • Male osteoporosis
      • Glucocorticoid-induced osteoporosis
      • Osteoarthritis
      • Osteogenesis imperfecta
    • Models of hormonal action
      • In vitro assay, androgenic activity
      • In vitro assay, estrogenic activity
      • Hershberger bioassay
      • Uterotrophic bioassay
    • Bone safety
    • Bone analysis services
    • Clinical biomarker services
    • Radiopharmaceuticals testing expertise
    • Pain assessment
    • Statistics
    • Why choose Pharmatest?
  • Facilities & equipment
  • Downloads
    • Fact sheets
    • White papers
    • Scientific presentations
      • Cancer
      • Skeletal
    • Scientific publications
  • News
  • Contact us